NATASHA GREENDYK: Open Payments
NPI 1073953048 · WEST MILFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 13 payments from 12 companies in 2025. Trend: 2023 $88 · 2024 $50 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $31 |
| Insulet Corporation | 1 | $27 |
| Soleno Therapeutics, Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| TOLMAR, INC. | 1 | $20 |
| BETA BIONICS, INC. | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
Products named: CRENESSITY, Sogroya, Omnipod, VYKAT XR, Dexcom G6 Transmitter, STRENSIQ, FENSOLVI, iLet Bionic Pancreas.
Industry payments across NJ — which companies pay providers there.
